2109 - HHV-6 and EBV Reactivation after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis: A Retrospective Cohort Study

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Eleftheria Kampouri, MD

Post-doctoral research fellow
Fred Hutchinson Cancer Center
Seattle, WA, United States

EK

Elizabeth M. Krantz, M.S.

Statistical Research Associate
Fred Hutch Cancer Center
Seattle, Washington, United States
Danniel Zamora, MD (he/him/his)

Infectious Diseases Acting Assistant Professor
Fred Hutchinson Cancer Center
Seattle, Washington, United States
LK

Louise E. Kimball, PhD

PhD
Fred Hutchinson Cancer Center
Seattle, Washington, United States
EK

Erika Kiem, n/a

Fred Hutchinson Cancer Center
Seattle, Washington, United States
EL

Erika A. Lovas, n/a

Fred Hutchinson Cancer Center
Seattle, Washington, United States
RB

Rachel Blazevic, BS

Program Assistant II
Fred Hutchinson Cancer Research Center
Seattle, WA, United States
TS

Terry L. Stevens-Ayers, MS

Research Technician
Fred Hutchinson Cancer Center
Seattle, Washington, United States
MH

Meei-Li Huang, PhD

Research Scientist
University of Washington
Seattle, Washington, United States
UM

Ueda Oshima Masumi, MD MA

Fred Hutchinson Cancer Center
Seattle, Washington, United States
KJ

Keith R. Jerome, MD PhD

Professor
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Danielle M. Zerr, MD MPH

Professor Pediatric Infectious Diseases/Med. Dir. Infection Prevention
University of Washington; Seattle Children's Research Institute
Seattle, Washington, United States
Michael J. Boeckh, MD PhD

Professor
Fred Hutchinson Cancer Center
Seattle, WA, United States
Joshua A. Hill, MD

Assistant Professor
Fred Hutchinson Cancer Center; University of Washington
Seattle, Washington, United States